Hoth Therapeutics (NASDAQ:HOTH) has entered into an exclusive licensing agreement to develop potential anti-obesity treatments based on technology co-developed by Emory University and the U.S ...

(RTTNews) - Hoth Therapeutics (HOTH) has entered into an exclusive patent license agreement with the U.S. Department of Veterans Affairs, providing the company with exclusive rights to a jointly ...

NEW YORK, Dec. 26, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative therapies, today announced that it has entered into an ...

(RTTNews) - Hoth Therapeutics (HOTH), a New York-based biopharmaceutical company, announces IP advancements with expanded patent applications for its therapeutic pipeline. The new patents ...

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, proudly announces advancements in its intellectual property portfolio ...